Clinical trial
A Phase 2 Trial of the Discussion of Cost (DISCO) App as an Intervention to Improve Financial Outcomes in Hematologic Cancer Patients
NCT04282343 is registered in ClinicalTrials.gov with Barbara Ann Karmanos Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Trial of the Discussion of Cost (DISCO) App as an Intervention to Improve Financial Outcomes in Hematologic Cancer Patients
- Lead sponsor
- Barbara Ann Karmanos Cancer Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 25, 2020
- Completion date
- October 21, 2022
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic lymphocytic leukemia, chronic myelogenous leukemia, bcr-abl1 positive, plasma cell myeloma